Invasive Conidiobolomycosis Can Be Successfully Treated on Burn Survivors.

Area of Science:

• Medical Mycology
• Infectious Diseases
• Critical Care Medicine

Background:

• Conidiobolus infection, a rare fungal disease, presents diagnostic and therapeutic challenges.
• Invasive conidiobolomycosis is infrequently reported, with limited successful treatment cases documented.
• Previous literature suggested Zygomycetes do not release detectable serum beta-D-glucan (BDG).

Observation:

• A burn survivor developed invasive Conidiobolus infection, a condition rarely seen in adults.
• The patient's infection was successfully managed through aggressive surgical intervention and specialized burn unit care.
• Serum BDG levels were monitored throughout the treatment course.

Findings:

• This case represents the first reported adult survivor of invasive conidiobolomycosis.
• Serum BDG levels were found to be a potentially useful biomarker for diagnosing and monitoring Conidiobolus infection.
• The findings contradict the prior belief that Zygomycetes do not yield detectable BDG levels.

Implications:

• Aggressive surgical management combined with intensive care is crucial for treating lethal invasive Conidiobolus infections.
• Serum BDG monitoring may offer a valuable tool for early diagnosis and effective management of Conidiobolus infections.
• This case expands the understanding of Conidiobolus infection treatment and diagnostic markers in immunocompromised patients.